Event Summary

meeting summary

02/12/24

U.S. Senate HELP: Why Does the United States Pay, by Far, the Highest Prices in the World for Prescription Drugs?

On Thursday, February 8, the U.S. Senate Committee on Health, Education, Labor, & Pensions (HELP) held a full committee hearing, featuring the CEOs of Johnson & Johnson, Merck, and Bristol Myers Squibb as witnesses, to discuss drivers and solutions for the nation’s high prescription drug costs and the roles that large pharmaceutical manufacturers may be playing in perpetuating increasing prices.

meeting summary

02/10/24

U.S. Senate Finance Committee – AI and Health Care: Promise and Pitfalls

On February 8, the U.S. Senate Committee on Finance held a full committee hearing to detail the role Congress and the Committee should play to ensure positive outcomes and set rules for AI-supported innovations in the American healthcare system.

meeting summary

02/8/24

CTA: Congressional Digital Health Caucus Launch – Exploring the Intersection of Health and AI

On February 1, 2024, the Consumer Technology Association (CTA) hosted a Congressional briefing to launch the bipartisan Digital Health Caucus, which will serve as a hub for tackling complex questions posed by new technologies in health care, like artificial intelligence (AI). Following the announcement of the Caucus by U.S. House Representatives Balderson and Kelly, a group of expert panelists discussed what their respective companies are currently working on and how AI will change the health care system.

meeting summary

02/8/24

Value-Based Payment Summit: Keynote with Jon Blum, CMS Principal Deputy Administrator

On January 29, 2024, at the Virtual Value-Based Payment Summit, Jon Blum, the Principal Deputy Administrator of CMS, gave a keynote talk to discuss the Administration’s progress on advancing value-based care and how it is now primarily focusing on increasing coordination between all payers and specialty care.

meeting summary

02/8/24

Value-Based Payment Summit: State of the Union Roundtable

On January 31, 2024, at the third Virtual Value-Based Payment Summit, a former Commissioner of the FDA and two former Secretaries of HHS gathered to discuss the challenges and opportunities of wider value-based care adoption.

meeting summary

02/8/24

Value-Based Payment Summit: Medicare Advantage Legal Developments

On February 2, 2024, at the third Virtual Value-Based Payment Summit, a panel of health lawyers explored how changes in risk adjustment and marketing requirement updates for Medicare Advantage impact the value-based care industry.

meeting summary

02/7/24

Value-Based Payment Summit: Medicare Advantage, What Does the Research Say

On January 30, 2024, at the Virtual Value-Based Payment Summit, a panel of Medicare Advantage (MA) experts discussed the current research on the value of MA. During this session, the speakers each gave brief overviews of different studies focused on MA in the context of value-based care (VBC).

meeting summary

02/7/24

Value-Based Payment Summit: Bringing the Late Majority into Value-Based Care

On January 31, the Value-Based Payment Summit hosted a session with leaders from Aledade and an independent physician who currently participates in an ACO. The discussion centered around the evolution of ACO participation, general awareness of value-based care participation options, and how to support independent physician practices.

meeting summary

02/7/24

Value-Based Payment Summit: Administration Perspectives on Accountable Care

On January 29, the Value-Based Payment Summit hosted a session with CMS leaders to discuss the Administration’s progress on its value-based care goals and to identify key initiatives for 2024.

meeting summary

02/7/24

U.S. House Energy & Commerce: Health Care Spending in the United States: Unsustainable for Patients, Employers, and Taxpayers

On Wednesday, January 31, the U.S. House Committee on Energy & Commerce held a Health Subcommittee hearing to discuss the nation’s high costs of health care, including the drivers behind increased spending in the public and private sectors, potential cost-cutting strategies, and the impact of high health care costs on patients, employers, and payers.